共 129 条
[1]
Kim EH(2015)Prostate-specific antigen-based screening: controversy and guidelines BMC Med 13 61-178
[2]
Andriole GL(2009)Strategies for repeat prostate biopsies Curr Urol Rep 10 172-1451
[3]
Terris MK(1997)Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer: a multi-institutional update JAMA 277 1445-537
[4]
Partin AW(1997)Evaluation of a nomogram used to predict the pathologic stage of clinically localized prostate carcinoma Cancer 79 528-771
[5]
Kattan MW(1998)A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer J Natl Cancer Inst 90 766-1507
[6]
Subong EN(1999)Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer J Clin Oncol 17 1499-1907
[7]
Walsh PC(2010)Global patterns of cancer incidence and mortality rates and trends Cancer Epidemiol Biomarkers Prev 19 1893-713
[8]
Wojno KJ(1999)Development of a nomogram that predicts the probability of a positive prostate biopsy in men with an abnormal digital rectal examination and a prostate-specific antigen between 0 and 4 ng/mL Urology 54 709-1422
[9]
Oesterling JE(2003)Predictive modeling for the presence of prostate carcinoma using clinical, laboratory, and ultrasound parameters in patients with prostate specific antigen levels < or = 10 ng/mL Cancer 98 1417-112
[10]
Kattan MW(2007)Prediction of indolent prostate cancer: validation and updating of a prognostic nomogram J Urol 177 107-534